<DOC>
	<DOC>NCT01355991</DOC>
	<brief_summary>To determine the acute and chronic effects of a short course of treatment on spinal cord injured (SCI) individuals with either an anticholinergic agent (tiotropium) or with a β₂ agonist (Salmeterol) on: - Fraction of expired NO (FeNO) - Selected Biomarkers of inflammation in exhaled breath condensates (EBC) - Pulmonary function, as measured by pulmonary function tests and body plethysmography</brief_summary>
	<brief_title>Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI</brief_title>
	<detailed_description />
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Cholinergic Antagonists</mesh_term>
	<criteria>1. Chronic Spinal Cord Injury (&gt;1 year postinjury) 2. All American Spinal Injury Association (ASIA) classifications 3. Stable tetraplegia (level of injury C3C8, nonventilator dependent) 4. Age 1865 years 1. Smoking, active or history of smoking within last 6 months; 2. Active respiratory disease; 3. Known history of asthma during lifetime or recent (within 3 months) respiratory infections; 4. Use of medications known to affect the respiratory system; 5. Use of medications known to alter airway caliber; 6. Coronary heart and/or artery disease; 7. Hypertension; 8. Adrenal insufficiency; 9. Pregnancy; 10. Severe Milk Protein Allergy; 11. Lack of mental capacity to give informed consent; 12. Previous allergic reaction or hypersensitivity to salmeterol or tiotropium; 13. Individuals taking medication(s) with known /potential drug interactions or suggested therapy modification for concomitant use with salmeterol or tiotropium such as: (1) selective alpha/beta blockers: carvedilol, labetalol; (2) nonselective betablockers: Carteolol; Levobunolol; Metipranolol; Nadolol; Penbutolol; Pindolol; Propranolol; Sotalol; Timolol); (3) CYP3A4 Inhibitors: (e.g, Atazanavir; Clarithromycin; Conivaptan; Darunavir; Delavirdine; Fosamprenavir; Imatinib; Indinavir; Isoniazid; Itraconazole; Ketoconazole; Lopinavir; Nefazodone; Nelfinavir; NiCARdipine; Posaconazole; QuiNIDine; Ritonavir; Saquinavir; Telithromycin; Voriconazole; (4) Iobenguane I 123 / Sympathomimetics: Albuterol; Aminophylline; Arformoterol; Armodafinil; Benzphetamine; Caffeine; Dexmethylphenidate; Dextroamphetamine; Diethylpropion; Dipivefrin; DOBUTamine; DOPamine; Doxapram; Dyphylline; EPHEDrine; EPINEPHrine; Fenoterol; Formoterol; Isometheptene; Levalbuterol; Levonordefrin; Lisdexamfetamine; Metaproterenol; Methamphetamine; Methylphenidate; Midodrine; Modafinil; Naphazoline; Norepinephrine; Oxymetazoline; Phendimetrazine; Phentermine; Phenylephrine; Pirbuterol; Propylhexedrine; Pseudoephedrine; Sibutramine; Terbutaline; Theophylline; Xylometazoline.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Spinal Cord Injury</keyword>
	<keyword>Tetraplegia</keyword>
	<keyword>Pulmonary Function</keyword>
	<keyword>Bronchodilator</keyword>
</DOC>